AlphaQuest’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,378
Closed -$32.4K 1604
2025
Q4
$32.4K Hold
9,378
﹤0.01% 2030
2025
Q3
$47.9K Hold
9,378
﹤0.01% 1948
2025
Q2
$49.6K Hold
9,378
﹤0.01% 1630
2025
Q1
$76.3K Hold
9,378
0.01% 1404
2024
Q4
$120K Buy
9,378
+1,858
+25% +$21.9K 0.02% 1045
2024
Q3
$80.6K Buy
7,520
+5,484
+269% +$51.5K 0.01% 1333
2024
Q2
$16.1K Sell
2,036
-8,512
-81% -$81K ﹤0.01% 1301
2024
Q1
$169K Buy
+10,548
New +$171K 0.03% 691

Other funds holding RCEL

AlphaQuest's RCEL Position: Q1 2026 in Review

AlphaQuest sold out of Avita Medical (RCEL) in Q1 2026, closing a stake of 9,378 shares — an estimated $32.4K sold.

AlphaQuest first reported a position in RCEL in Q1 2024 and held it in 8 quarters. The position peaked at $169K in Q1 2024. 79 funds tracked by Wall St. Rank hold RCEL as of Q1 2026.

  • AlphaQuest reported no remaining Avita Medical position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 9,378 Avita Medical shares in Q1 2026, an estimated $32.4K.
  • AlphaQuest first reported a position in Avita Medical in Q1 2024 and held it in 8 quarters.
  • AlphaQuest's Avita Medical position peaked at $169K in Q1 2024.
  • 79 funds tracked by Wall St. Rank held Avita Medical as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.